CLINICAL_TRIALS
trial_result
· 2021-07-27
Clinical Trial Update: Study of Rivoglitazone in Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 clinical trial update for rivoglitazone in type 2 diabetes mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2021-07-27